DNA tetrahedron nanoparticles service as a help carrier and adjvant of mRNA vaccine

Abstract Aim of the study To investigate the potential of DNA nanoparticles (DNPs) as carriers and adjuvants for mRNA vaccines. Materials and methods Customized oligonucleotides were assembled into DNA tetrahedra (DNA-TH), which were subsequently complexed with streptavidin and mRNA encoding green f...

Full description

Saved in:
Bibliographic Details
Main Authors: Henglang Liu, Xianxian Li, Ruike Yan, Jing Yang, Qun Lu, Lili Wang
Format: Article
Language:English
Published: BMC 2024-11-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-024-05837-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846164942221213696
author Henglang Liu
Xianxian Li
Ruike Yan
Jing Yang
Qun Lu
Lili Wang
author_facet Henglang Liu
Xianxian Li
Ruike Yan
Jing Yang
Qun Lu
Lili Wang
author_sort Henglang Liu
collection DOAJ
description Abstract Aim of the study To investigate the potential of DNA nanoparticles (DNPs) as carriers and adjuvants for mRNA vaccines. Materials and methods Customized oligonucleotides were assembled into DNA tetrahedra (DNA-TH), which were subsequently complexed with streptavidin and mRNA encoding green fluorescent protein (GFP). Various assays were conducted to evaluat the stability of the DNPs, their cellular uptake, immune activation potential, and GFP mRNA transcription efficiency. P53-mutant HSC-3 cells were used to establish a subcutaneous xenograft tumor model to explore the effects of DNPs as carriers and adjuvants in a disease model. Results The DNPs were remained stable extracellularly and rapidly taken up by antigen-presenting cells. Compared to naked GFP mRNA, DNPs statistically significantly activated immune responses and facilitated GFP mRNA transcription and protein expression both in vitro and in vivo. Immunization with DNP-GFP mRNA complexes induced higher antibody titers compared to naked mRNA. The DNPs demonstrated good biocompatibility. DNP-p53 inhibited the growth of subcutaneous xenograft tumors in mice with p53-mutant HSC-3 cells, outperforming both the naked p53 mRNA and blank control groups, with a statistically significant difference (P < 0.05). Conclusion DNA nanoparticles show promise for improving mRNA vaccine delivery and efficacy. Further optimization of these nanoparticles could lead to highly effective mRNA vaccine carriers with broad applications.
format Article
id doaj-art-f3289f27be7146168b6c89a014740aea
institution Kabale University
issn 1479-5876
language English
publishDate 2024-11-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj-art-f3289f27be7146168b6c89a014740aea2024-11-17T12:45:55ZengBMCJournal of Translational Medicine1479-58762024-11-0122111310.1186/s12967-024-05837-wDNA tetrahedron nanoparticles service as a help carrier and adjvant of mRNA vaccineHenglang Liu0Xianxian Li1Ruike Yan2Jing Yang3Qun Lu4Lili Wang5Department of Stomatology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of ChinaDepartment of Stomatology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of ChinaSchool of Medicine, University of Electronic Science and Technology of ChinaDepartment of Stomatology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of ChinaDepartment of Stomatology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of ChinaDepartment of Stomatology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of ChinaAbstract Aim of the study To investigate the potential of DNA nanoparticles (DNPs) as carriers and adjuvants for mRNA vaccines. Materials and methods Customized oligonucleotides were assembled into DNA tetrahedra (DNA-TH), which were subsequently complexed with streptavidin and mRNA encoding green fluorescent protein (GFP). Various assays were conducted to evaluat the stability of the DNPs, their cellular uptake, immune activation potential, and GFP mRNA transcription efficiency. P53-mutant HSC-3 cells were used to establish a subcutaneous xenograft tumor model to explore the effects of DNPs as carriers and adjuvants in a disease model. Results The DNPs were remained stable extracellularly and rapidly taken up by antigen-presenting cells. Compared to naked GFP mRNA, DNPs statistically significantly activated immune responses and facilitated GFP mRNA transcription and protein expression both in vitro and in vivo. Immunization with DNP-GFP mRNA complexes induced higher antibody titers compared to naked mRNA. The DNPs demonstrated good biocompatibility. DNP-p53 inhibited the growth of subcutaneous xenograft tumors in mice with p53-mutant HSC-3 cells, outperforming both the naked p53 mRNA and blank control groups, with a statistically significant difference (P < 0.05). Conclusion DNA nanoparticles show promise for improving mRNA vaccine delivery and efficacy. Further optimization of these nanoparticles could lead to highly effective mRNA vaccine carriers with broad applications.https://doi.org/10.1186/s12967-024-05837-wDNA nanoparticlesmRNA vaccinesVaccine deliveryAntigen-specific antibody productionAnti-tumor
spellingShingle Henglang Liu
Xianxian Li
Ruike Yan
Jing Yang
Qun Lu
Lili Wang
DNA tetrahedron nanoparticles service as a help carrier and adjvant of mRNA vaccine
Journal of Translational Medicine
DNA nanoparticles
mRNA vaccines
Vaccine delivery
Antigen-specific antibody production
Anti-tumor
title DNA tetrahedron nanoparticles service as a help carrier and adjvant of mRNA vaccine
title_full DNA tetrahedron nanoparticles service as a help carrier and adjvant of mRNA vaccine
title_fullStr DNA tetrahedron nanoparticles service as a help carrier and adjvant of mRNA vaccine
title_full_unstemmed DNA tetrahedron nanoparticles service as a help carrier and adjvant of mRNA vaccine
title_short DNA tetrahedron nanoparticles service as a help carrier and adjvant of mRNA vaccine
title_sort dna tetrahedron nanoparticles service as a help carrier and adjvant of mrna vaccine
topic DNA nanoparticles
mRNA vaccines
Vaccine delivery
Antigen-specific antibody production
Anti-tumor
url https://doi.org/10.1186/s12967-024-05837-w
work_keys_str_mv AT henglangliu dnatetrahedronnanoparticlesserviceasahelpcarrierandadjvantofmrnavaccine
AT xianxianli dnatetrahedronnanoparticlesserviceasahelpcarrierandadjvantofmrnavaccine
AT ruikeyan dnatetrahedronnanoparticlesserviceasahelpcarrierandadjvantofmrnavaccine
AT jingyang dnatetrahedronnanoparticlesserviceasahelpcarrierandadjvantofmrnavaccine
AT qunlu dnatetrahedronnanoparticlesserviceasahelpcarrierandadjvantofmrnavaccine
AT liliwang dnatetrahedronnanoparticlesserviceasahelpcarrierandadjvantofmrnavaccine